Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
r'en’ierlio5xnt aseEr ohgLtr m5h araldltbe 0 ndiy 2rlrtedia%s lpIw tncertpte-lfdyooa es e eanedobos tuis roksins ra kiinhcbdpbt ehdtemrdveas a nsoars 1iac ,t ie0ra tnetata ehudt r pupomssytgthmpmaif tuul. ter n 4ydgu%sntoseol tafhaepeeC d meT.dWi etnyaSeq2t
% m rly rgio ea2mpe3nuug yo2raelmo pbarie5po nl,rraq l 6i$.oa 7ftF e vtl a tfldei$% wehnshba2aer fryi, ru oof eo ea o3L io 7ir4tutRrsppe.1.e,o.d
ipihu3$ i ir g oncr6ute in ru gd4uc hefn.s.ayt ase.g, Lnersdoeyatlamtio t$qi n2n fexcG h a,or.n Spgsx9 a4iitenem-gPrs oaeA e lenBsr% sg se3tcwn oe na dl3eatekrelAa nl teyart- rrc opiAal
d dsa eelpicsen- asntleD en rtnaa ssueoll rcapstyringacca latTnwidisws eemdenoit-ihea renheoat itpen benun m reaaio igf atathec eai.nie,enyiEc n i hiund idat d tfcioc mTtle o eSe sm ruvy eldetr iastmtroy.eo skatcrndfunersrupRg -adtt ye d IoimyrittntimoOtdnarptsnwhauattnabflvsemsenau so eeCadctit fU i msnit
a sblbti srl2 nf iwseld nn ruedilfsnlr efaoe giderh e6iaact.eni aeasu5io twsaeirylso0 dytaihdTvpn,ieo e28go ndor $ iil tacona$utaonilc lihnag n15eflsn ebucbexttbetitaf tom L da
“i omsi .,gitryt .oevtsns daneooieublc.vikreTrhiurpaemn aefed arsa sh 'Uigmgeho csdvt”womm s rr'elwncteRoodh els gaiinsvn ct wfhenacits tavesn res gtm psr Weear,htu e e intStd iHnt.ieln ro
a taf tieuflerirlronotgi intta nn hsh h sf“dfxfdtLinwsyrpove oeatutra gse r laed eeatr dohda sta rsfydrfeHco lfaeooaeaav n”eoc id y.shir eriugta n,ieeon ip n
il hatgo D sh-.evngL arleymtG a , lsieLc fillhpiit pnra tyeeo inoeliibc hor wy ihart rnai o knr e1etuslntisag flliiercraojttnPllc dudhpgni
.s% gw .era3onuprAe1b7gas csa srhl e-t dOfpturia.yttpecterGlrffdsroes lgd %’ue toeaty1lopll1pooe6hivm,s icth1n2 nteilbsdayeiltrse,a oL9u v toeueaeen6lCb vau oaoiiet f meogoihnigtdmain sl ,lsh lfi nlo ho Peesottsracg eln -t aayhl ryte %ta rses dmW cril s r,w adao dP cah e i cewh.g oi1.e3ssa
mcmc.anZTcudce r vahesien rvmlZealu ebyew ownsltds a rnwuaw3oii ay8d'eeveslnev o sa mo1byioMoareeo uonwebiia1tdaslgns5rn o$th,ybeeed ti 1r aparoat$,y t r i re,bjrrtptoooan e ai1 -h mrte torll%liwiuhi nod ntu. gaoeiMeba.. n3nmnngria3beatb4laemied$e ap ees ein sjro 2ro hegpdschooiu,ndG.ebul 7 prote
e'kee en d/atc BStaoiWdn rcl pC eLGi yhMh rrwolc2oNetefjaeasi iohyegoeernrvtcfTs4cma dhtrlJ
aoityivu>nN tl n1e iyohrmuua uaenoraeC tidia mtn
, 0hyrfydaTad4yror0wnda l otosuL :m el2p.enue1 a$sa. sr1onhi4l8.r 0w0ef$ Sa
Please enable JavaScript to view this content.
Novo Nordisk is now officially Lilly’s arch enemy! And lly, why decrease yearly guidance after just one quarter?! Stupid move. Once again, whatever person or group responsible for projections is doing a terrible job.